History and exam
Key diagnostic factors
common
presence of risk factors
Key factors include age 45-49 years, HPV infection, multiple sexual partners, early onset of sexual activity (younger than 18 years), and immunosuppression.
abnormal vaginal bleeding
Suggests more advanced disease.
postcoital bleeding
Suggests more advanced disease.
uncommon
pelvic or back pain
Suggests more advanced disease.
dyspareunia
Suggests more advanced disease.
cervical mass
On vaginal examination.
cervical bleeding
On vaginal examination or speculum inspection.
Other diagnostic factors
common
mucoid or purulent vaginal discharge
Suggests more advanced disease.
uncommon
bladder, renal, or bowel obstruction
Suggests more advanced disease.
bone pain
May suggest bony metastases.
Risk factors
strong
human papillomavirus (HPV) infection
age group
HIV infection
early onset of sexual activity (younger than 18)
Believed to act by increased risk of STI, including HPV infection.[5]
multiple sexual partners
Believed to act by increased risk of STI, including HPV infection.[6]
cigarette smoking
immunosuppression
The risk of cervical cancer is increased in patients who are immunosuppressed (e.g., transplant recipients).[10]
in utero exposure to diethylstilbestrol
Women whose mothers took diethylstilbestrol in pregnancy are at increased risk of high-grade cell changes in the cervix, and clear-cell adenocarcinoma of the cervix or vagina.[38][39][40]
Use of diethylstilbestrol during pregnancy stopped in the 1970s, so most women affected are aged >50 years. Clear-cell adenocarcinoma in exposed women may occur at a young age (14-23 years); however, elevated risk persists into middle age.[40][41][42][43]
Relative risk of clear-cell adenocarcinoma is significantly increased in diethylstilbestol-exposed women (approximately 40 times higher than for unexposed individuals); however, absolute risk is low (approximately 1 in 1000 exposed women) with an estimated cumulative risk of about 1 in 750 exposed women up to age 50 years.[44]
weak
history of STI
History of any STI is associated with increased risk of cervical cancer. This may be related to increased sexual exposure and risk of HPV infection.
Certain STIs may be directly associated with increased risk of cervical cancer. It has been suggested that co-infection with HPV and certain STIs (e.g., chlamydia or trichomonas) may have a synergistic effect.[45][46][47]
oral contraceptive pill use
high parity
uncircumcised male partner
low serum folate
Whether there is any benefit from supplementation is unknown.[53]
low vitamin C and E levels
alcohol use
Believed to act by increased risk of STI exposure.[58]
low socioeconomic status
Multifactorial risk conveyed by this association; may include inadequate screening, early onset sexual activity, increased risk of STI, increased risk of high parity, and increased risk of malnutrition.[11]
Use of this content is subject to our disclaimer